PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-100.00%
Negative revenue growth while NHC.AX stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-100.00%
Negative gross profit growth while NHC.AX is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
10.60%
EBIT growth of 10.60% while NHC.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
10.60%
Operating income growth of 10.60% while NHC.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
13.84%
Net income growth of 13.84% while NHC.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
23.33%
EPS growth of 23.33% while NHC.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
23.33%
Diluted EPS growth of 23.33% while NHC.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
16.66%
Share change of 16.66% while NHC.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
16.66%
Diluted share change of 16.66% while NHC.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-46.46%
Negative OCF growth while NHC.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-93.76%
Negative FCF growth while NHC.AX is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-100.00%
Negative 10Y revenue/share CAGR while NHC.AX stands at 525.55%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while NHC.AX stands at 304.87%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while NHC.AX stands at 100.84%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-25.54%
Negative 10Y OCF/share CAGR while NHC.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-25.54%
Negative 5Y OCF/share CAGR while NHC.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-25.54%
Negative 3Y OCF/share CAGR while NHC.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
26.15%
10Y net income/share CAGR of 26.15% while NHC.AX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
26.15%
Below 50% of NHC.AX's 201.82%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
26.15%
3Y net income/share CAGR 50-75% of NHC.AX's 49.55%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-14.28%
We have a declining book value while NHC.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.64%
We cut SG&A while NHC.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.